A recent re-analysis of patient-level data from multiple AD clinical trials found that long-term use of various statins resulted in lower rates of cognitive decline, with potentially greater therapeutic efficacy in APOE ε4/ε4 carriers [28]. The gene discussed is APOE; the disease is Mental deterioration.